Governments Continue to Obscure Covid-19 Vaxx Data Amid Rising Concerns Over Excess Deaths

• The FDA initially tried to hide Pfizer’s COVID vaccine trial data for 55 years, then extended it to 75 years, claiming insufficient staff. A federal judge forced partial disclosure, but the FDA continues resisting full transparency.

• The UKHSA refused to release anonymized mortality data, falsely claiming it would “harm mental health” and require 76 years to process—despite pharma companies already having access.

• VAERS reports 31,569 deaths, 53,302 myocarditis cases and 59,127 permanently disabled—likely undercounted by 95% to 99%. Australia quietly budgeted $77 million for vaccine injury payouts in 2023 alone.

• Peer-reviewed studies link vaccines to increased cancer rates, immune dysfunction and serious adverse events, yet governments dismiss findings as “long COVID” or pre-existing conditions.

• From the U.S. to the U.K., governments are actively hiding autopsy reports, delaying FOIA requests and blocking independent scrutiny, raising the question: If vaccines are safe, why hide the data?

(Natural News)—Nearly five years after the Wuhan coronavirus (COVID-19) vaccines were rushed to market under emergency authorization, governments worldwide continue to withhold critical data that could clarify the true risks and benefits of these experimental treatments. A recent ruling by a U.K. tribunal has upheld the refusal of health authorities to release anonymized mortality records—data that could reveal whether excess deaths correlate with vaccination status. This decision mirrors similar obstruction tactics employed by the U.S. Food and Drug Administration (FDA), which previously sought to delay the release of Pfizer’s COVID-19 vaccine trial data for 75 years—a move that was ultimately overturned by a federal judge.

U.K. tribunal shields vaccine data under dubious pretenses

The U.K. Health Security Agency (UKHSA) successfully argued before the tribunal that releasing anonymized vaccination and mortality records could “seriously harm the mental health of surviving relatives” and would require 76 years of processing to ensure individuals could not be identified. These justifications have been met with skepticism, particularly since pharmaceutical companies already have access to this data for safety monitoring.

More